Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/13/1992 | CA1308662C Spray dried acetaminophen |
10/13/1992 | CA1308657C Hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
10/13/1992 | CA1308656C Hydrosols of pharmacalogically active agents and their pharmaceutical compositions comprising them |
10/13/1992 | CA1308655C Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same |
10/13/1992 | CA1308602C Method for solubilization of aspartame in effervescent aqueous systems; and composition |
10/11/1992 | CA2106857A1 Novel cytarabine derivatives, their production and use |
10/09/1992 | WO1992017166A1 Capsule |
10/09/1992 | CA2107678A1 Capsule |
10/09/1992 | CA2064150A1 Sustained release pharmaceutical preparation and process for preparing the same |
10/07/1992 | EP0507696A1 Antihistaminic and non-sedative derivatives of benzimidazol, process for their preparation and their medicinal use |
10/07/1992 | EP0507693A1 Triple emulsion cosmetic composition |
10/07/1992 | EP0507629A1 Sustained release capsule and formulations for insertion into rumen |
10/07/1992 | EP0507573A2 Readily absorbable motilin preparations |
10/07/1992 | EP0507484A1 A pharmaceutical formulation of aureobasidins |
10/07/1992 | EP0507224A2 Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
10/07/1992 | EP0507160A1 External preparation for application to the skin containing lidocaine |
10/07/1992 | EP0507047A2 Emulsifiers for preparing oil-in-water emulsions of etheric oils useful for cosmetic on medical purposes |
10/07/1992 | EP0506900A1 Process for producing spagyric essences from plants. |
10/07/1992 | EP0506860A1 Nicotine packaging materials |
10/07/1992 | EP0506844A1 Sustained flavorant release composition, method for making same and chewable structure incorporating same |
10/07/1992 | EP0506840A1 Method of treating ocular diseases by periocular administration of cyclosporine a or g |
10/07/1992 | EP0506793A1 A method for applying a hard coating on cores of adible or chewable material and coated material obtained by the method. |
10/07/1992 | EP0506792A1 Insulin preparations containing nicotinic acid or nicotinamide. |
10/07/1992 | EP0506785A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
10/07/1992 | EP0506774A1 Smoking substitute. |
10/07/1992 | EP0493380A4 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
10/07/1992 | EP0339035B1 Hydrogel-containing envelopes |
10/07/1992 | EP0295242B1 Freeze-dried foam |
10/07/1992 | CN1065011A Making method of analgesic and antipruritic plaster |
10/07/1992 | CN1065010A Steroid formultions |
10/07/1992 | CN1065009A Process for preparing composition for beauty or pharmaceutical, especially dermtoses and anti-allergy and use |
10/07/1992 | CN1065008A Preparation method of medical extract for treating diarrhea due to cold |
10/07/1992 | CN1065007A Preparation method of plaster for treating anorexia |
10/07/1992 | CN1018521B Intrauterine contraceptive device |
10/06/1992 | USRE34089 Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant |
10/06/1992 | US5153221 Method for the treatment of acquired immune deficiency syndrome |
10/06/1992 | US5153219 Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
10/06/1992 | US5153179 Medicament with improved penetration of the tissue membrane |
10/06/1992 | US5153177 Process for incorporating a material in a crosslinked gelatin, and product therefrom |
10/06/1992 | US5153174 Polymer mixtures useful in skin care |
10/06/1992 | US5153002 Biocompatible gradient controlled release implant |
10/06/1992 | US5153001 Oral administration of mixture of nifedipine and vitamin E to increase fluidity of circulating blood, vasodilation |
10/06/1992 | US5153000 Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome |
10/06/1992 | US5152999 Adriamycin entrapped cholesterol derivatives having a negative charge |
10/06/1992 | US5152997 Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
10/06/1992 | US5152991 Use of selectively hydrogenated styrene/butadiene copolymers in cosmetic and pharmaceutical compositions |
10/06/1992 | US5152986 Preparation and use of ion exchange resins loaded with quinolonecarboxylic acid derivatives |
10/06/1992 | US5152923 Process for the production of a nanoemulsion of oil particles in an aqueous phase |
10/06/1992 | US5152758 Electroresponsive hydrogel and physiologically active substance release control system |
10/06/1992 | US5152757 System for diagnosis and treatment of wounds |
10/06/1992 | CA2065219A1 Cosmetic composition in triple emulsion form |
10/06/1992 | CA2065061A1 Benzimidazole-derived non sedative antihistamines |
10/06/1992 | CA1308358C Antibacterial lyophilized preparation |
10/06/1992 | CA1308357C Method for the preparation of a coated solid medicament |
10/06/1992 | CA1308356C Porous microspheres for drug delivery and method for making same |
10/06/1992 | CA1308355C Biocompatible implants |
10/06/1992 | CA1308354C Veterinary compositions |
10/06/1992 | CA1308353C Preparation of solid pharmaceutical forms |
10/06/1992 | CA1308241C Nonwoven materials |
10/05/1992 | WO1992017164A1 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
10/05/1992 | WO1992017161A1 Chewable antacid compositions |
10/03/1992 | WO1992017216A1 Delivery of x-ray contrast agents using receptor mediated endocytosis |
10/03/1992 | CA2105068A1 Delivery of x-ray contrast agents using receptor mediated endocytosis |
10/03/1992 | CA2063968A1 Pharmaceutical formulation of aureobasidins |
10/01/1992 | WO1992016240A1 Debridement of bodily cavities using debridement fluids |
10/01/1992 | WO1992016214A1 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) |
10/01/1992 | WO1992016212A1 Increasing the therapeutic efficiency of macrophage-targeted therapeutic agents by up-regulating the mannose lectin on macrophages |
10/01/1992 | WO1992016210A1 Novel liquid compositions based on derivatives of 1,4 substituted piperidine |
10/01/1992 | WO1992016209A1 Granules and veterinary compositions comprising a water-soluble complex of flumequine |
10/01/1992 | WO1992016206A1 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) |
10/01/1992 | WO1992016202A1 Percutaneous anaesthesia |
10/01/1992 | WO1992016201A1 Method for inactivating enveloped viruses and sperm |
10/01/1992 | WO1992016199A1 Method and products for treating the eye |
10/01/1992 | WO1992016198A2 Method and products for treating the eye |
10/01/1992 | WO1992016196A1 A composition comprising a peptide for nasal administration |
10/01/1992 | WO1992016194A1 Space- and stability-efficient delivery device |
10/01/1992 | WO1992016193A1 Polylactic acid-based implant susceptible of bioresorption containing an antibiotic |
10/01/1992 | WO1992016191A1 Long-acting pharmaceutical preparation |
10/01/1992 | WO1992016184A1 Fat compositions and their use in cosmetic and pharmaceutical emulsion products |
10/01/1992 | WO1992016182A2 Method for inactivating enveloped viruses and sperm |
10/01/1992 | DE4110087A1 Benfotiamine-contg. pharmaceutical for topical use - is for treating e.g. rheumatic disorders, sciatica, lumbago, migraine etc. and other disorders beneficially affected by vitamin=B |
10/01/1992 | DE4110027A1 Transdermales therapeutisches pflaster Transdermal therapeutic plaster |
10/01/1992 | CA2064288A1 Emulsifiers for the preparation of oil-in-water emulsions of ethereal oils usable in cosmetics and medicine |
09/30/1992 | EP0506563A1 Suspension containing alginic acid |
09/30/1992 | EP0506300A2 Tacky, hydrophilic gel dressings and products therefrom |
09/30/1992 | EP0506219A2 Method for increasing the proportion of a crystalline organic compound which remains uncrystallized in a composite particulate product and suppressing recrystallization |
09/30/1992 | EP0506197A1 Topical preparation containing a suspension of solid lipid particles |
09/30/1992 | EP0506124A1 Methods and substances for recruiting therapeutic agents to solid issues comprising two single chain VH-VL bifunctional binding molecules |
09/30/1992 | EP0505966A1 Long-acting biodegradable microparticles and process for preparation |
09/30/1992 | EP0505872A1 Swallable tablet with a high content of edible organic acid salts |
09/30/1992 | EP0505478A1 A treatment system for wounds and other disorders and a method for treating wounds and other skin disorders. |
09/30/1992 | EP0505474A1 Antiperspirant. |
09/30/1992 | EP0505374A1 Vitamin-mineral treatment methods and compositions. |
09/30/1992 | EP0449983A4 Encapsulation of parasiticides |
09/30/1992 | CN1064865A 4-((2-benzothiazolyl) methylamino)-alpha-((3,4-difluorophinoxy) methyl)-1-piperidineethanol |
09/30/1992 | CN1064813A Methods and compositions for treatment and repair of defects or lesions in cartilage |
09/30/1992 | CN1064810A Low dose dry pharmaceutical preparations |
09/30/1992 | CN1064806A Magnetic adhesive plaster with medicine |
09/30/1992 | CN1018425B Specially-made acanthopanax root health inholant product and manufacturing method thereof |
09/29/1992 | US5151434 Controlled-release composition and the preparation thereof |